Literature DB >> 18622385

Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors.

Georges J Netto1, Yasutomo Nakai, Masashi Nakayama, Sana Jadallah, Antoun Toubaji, Norio Nonomura, Roula Albadine, Jessica L Hicks, Jonathan I Epstein, Srinivasan Yegnasubramanian, William G Nelson, Angelo M De Marzo.   

Abstract

Alterations in methylation of CpG dinucleotides at the 5 position of deoxycytidine residues (5(m)C) are a hallmark of cancer cells, including testicular germ cell tumors. Virtually all testicular germ cell tumors are believed to be derived from intratubular germ cell neoplasia unclassified (IGCNU), which is thought to arise from primordial germ cells. Prior studies revealed that seminomas contain reduced levels of global DNA methylation as compared with nonseminomatous germ cell tumors. Smiraglia et al have proposed a model whereby seminomas arise from IGCNU cells derived from primordial germ cells that have undergone 5(m)C erasure, and nonseminomas arise from IGCNU cells derived from primordial germ cells that have already undergone de novo methylation after the original erasure of methylation and contain normal 5(m)C levels. Yet the methylation status of IGCNU has not been determined previously. We used immunohistochemical staining against 5(m)C to evaluate global methylation in IGCNU and associated invasive testicular germ cell tumors. Strikingly, staining for 5(m)C was undetectable (or markedly reduced) in the majority of IGCNU and seminomas, yet there was robust staining in nonseminomatous germ cell tumors. The lack of staining for 5(m)C in IGCNU and seminomas was also found in mixed germ cell tumors containing both seminomatous and nonseminomatous components. Lack of 5(m)C staining was not related to a lack of the maintenance methyltransferase (DNA methyltransferase 1) protein. We conclude that testicular germ cell tumors are derived in most cases from IGCNU cells that have undergone developmentally programmed 5(m)C erasure and that the degree of subsequent de novo methylation is most closely related to the differentiation state of the neoplastic cells. That is, IGCNU cells and seminoma cells remain unmethylated, whereas all other histological types appear to arise after de novo methylation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18622385      PMCID: PMC4086525          DOI: 10.1038/modpathol.2008.127

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  36 in total

1.  Chromosomal instability and tumors promoted by DNA hypomethylation.

Authors:  Amir Eden; François Gaudet; Alpana Waghmare; Rudolf Jaenisch
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

Review 2.  Gene silencing in cancer in association with promoter hypermethylation.

Authors:  James G Herman; Stephen B Baylin
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245

Review 3.  The history of cancer epigenetics.

Authors:  Andrew P Feinberg; Benjamin Tycko
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

4.  Pattern of nonspecific (or global) DNA methylation in oral carcinogenesis.

Authors:  Chandrika J Piyathilake; Walter C Bell; Jennifer Jones; Olga L Henao; Douglas C Heimburger; Alain Niveleau; William E Grizzle
Journal:  Head Neck       Date:  2005-12       Impact factor: 3.147

Review 5.  Gamete imprinting: setting epigenetic patterns for the next generation.

Authors:  Jacquetta M Trasler
Journal:  Reprod Fertil Dev       Date:  2006       Impact factor: 2.311

6.  Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors.

Authors:  Dominic J Smiraglia; Jadwiga Szymanska; Sigrid M Kraggerud; Ragnhild A Lothe; Päivi Peltomäki; Christoph Plass
Journal:  Oncogene       Date:  2002-05-30       Impact factor: 9.867

7.  Global DNA methylation evaluation: potential complementary marker in differential diagnosis of thyroid neoplasia.

Authors:  Bogdan Galusca; Jean Marc Dumollard; Sandrine Lassandre; Alain Niveleau; Jean Michel Prades; Bruno Estour; Michel Peoc'h
Journal:  Virchows Arch       Date:  2005-05-13       Impact factor: 4.064

8.  DNMT1 and DNMT3b cooperate to silence genes in human cancer cells.

Authors:  Ina Rhee; Kurtis E Bachman; Ben Ho Park; Kam-Wing Jair; Ray-Whay Chiu Yen; Kornel E Schuebel; Hengmi Cui; Andrew P Feinberg; Christoph Lengauer; Kenneth W Kinzler; Stephen B Baylin; Bert Vogelstein
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

Review 9.  Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?

Authors:  Stephen B Baylin; Joyce E Ohm
Journal:  Nat Rev Cancer       Date:  2006-02       Impact factor: 60.716

Review 10.  DNA methylation in cancer: too much, but also too little.

Authors:  Melanie Ehrlich
Journal:  Oncogene       Date:  2002-08-12       Impact factor: 9.867

View more
  50 in total

Review 1.  Cancer epigenetics: above and beyond.

Authors:  Mariana Brait; David Sidransky
Journal:  Toxicol Mech Methods       Date:  2011-05       Impact factor: 2.987

2.  Hypomethylation, endogenous retrovirus expression, and interferon signaling in testicular germ cell tumors.

Authors:  Michael C Haffner; Diana Taheri; Eddie Luidy-Imada; Doreen N Palsgrove; Marie-Lisa Eich; George J Netto; Andres Matoso; Thomas R Nirschl; Qizhi Zheng; Jessica L Hicks; William G Nelson; Angelo M De Marzo; Luigi Marchionni; Charles G Drake; Srinivasan Yegnasubramanian
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-04       Impact factor: 11.205

3.  Reply to Haffner et al.: DNA hypomethylation renders tumors more immunogenic.

Authors:  Meredith L Stone; Katherine B Chiappinelli; Huili Li; Lauren M Murphy; Meghan E Travers; Michael J Topper; Dimitrios Mathios; Michael Lim; Ie-Ming Shih; Tian-Li Wang; Chien-Fu Hung; Vipul Bhargava; Karla R Wiehagen; Glenn S Cowley; Kurtis E Bachman; Reiner Strick; Pamela L Strissel; Stephen B Baylin; Cynthia A Zahnow
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-04       Impact factor: 11.205

4.  High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors.

Authors:  Maroun J Beyrouthy; Kristen M Garner; Mary P Hever; Sarah J Freemantle; Alan Eastman; Ethan Dmitrovsky; Michael J Spinella
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

5.  Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control.

Authors:  Juliette Gimenez; Cécile Montgiraud; Jean-Philippe Pichon; Bertrand Bonnaud; Maud Arsac; Karine Ruel; Olivier Bouton; François Mallet
Journal:  Nucleic Acids Res       Date:  2010-01-06       Impact factor: 16.971

6.  Cripto: Expression, epigenetic regulation and potential diagnostic use in testicular germ cell tumors.

Authors:  Cassy M Spiller; Ad J M Gillis; Guillaume Burnet; Hans Stoop; Peter Koopman; Josephine Bowles; Leendert H J Looijenga
Journal:  Mol Oncol       Date:  2015-11-18       Impact factor: 6.603

7.  LINE-1 methylation is inherited in familial testicular cancer kindreds.

Authors:  Lisa Mirabello; Sharon A Savage; Larissa Korde; Shahinaz M Gadalla; Mark H Greene
Journal:  BMC Med Genet       Date:  2010-05-17       Impact factor: 2.103

8.  Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options.

Authors:  Michael C Risk; Timothy A Masterson
Journal:  Indian J Urol       Date:  2010 Jan-Mar

Review 9.  [Advances in basic research on testicular germ cell tumors : clinical implications].

Authors:  L H J Looijenga
Journal:  Urologe A       Date:  2009-04       Impact factor: 0.639

Review 10.  Lessons from human teratomas to guide development of safe stem cell therapies.

Authors:  Justine J Cunningham; Thomas M Ulbright; Martin F Pera; Leendert H J Looijenga
Journal:  Nat Biotechnol       Date:  2012-09       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.